Safe microwave ablation of liver cancer in an elderly patient
2
neutrals-100
Physician: Roberto Chiavaroli MD
Location: Surgical Unit Ferrari Hospital, Casarano, Italy
Featured Product: TATO Thermal Ablation Treatments for Oncology
neutrals-100
true
ClinicalCase
Clinical Case
Procedure
Procedure
Follow-upConclusion
Follow-up/Conclusion
Clinical Case
3
neutrals-100
CF, 86-year-old man with HBV infection and liver cirrhosis (CHILD A5, MELD score 7 - oesophageal varices F0) with unifocal HCC 26 mm in size in the right lobe (VIII liver segment) detected by contrast enhanced CT in February 2017 (Fig.1). PSTO (stage A-BCLC classification) AFP 96 ng/mL. The patient refused to be submitted to surgical evaluation.
grid-texts-50
image-media-type
aspect-ratio-4-3
media-right
Procedure
3
neutrals-100
The patient underwent a percutaneous MW ablation session by US-guided insertion of two 17G antennas (60 watts for 10 minutes) under general anesthesia.
neutrals-100
Follow-up/Conclusion
3
neutrals-100
The procedure was well tolerated and CT control scan 30 days later showed a homogeneous 3.7 × 2.5 ablation zone (Fig. 2), without enhancement in the arterial phase. Using thin applicators and working on low power, the operator minimizes risk of side effects and can use percutaneous thermal ablation to safely treat HCC even in elderly patients.
grid-texts-50
image-media-type
aspect-ratio-4-3
Products Used
3
neutrals-100
Ablation session using a 2,45Ghz TATO system (Thermal Ablation Treatments for Oncology) and two TATOpro 17G antennas.
neutrals-100
Featured products
3
default-carousel
true
default-carousel
TATO Thermal Ablation Treatments for Oncology
TATO
Thermal Ablation Treatments for Oncology